Cardinal Health Inc (CAH)

Experts have mixed yet constructive views on Cardinal Health Inc. The acquisition of a urology company has been positively received, and one expert targets a price of $300 per share, suggesting that there is significant growth potential. Additionally, Cardinal Health is recognized as one of the three major distributors in the healthcare sector, benefitting from favorable demographic trends, particularly the aging population, which is expected to drive increased healthcare consumption. The company currently trades at a forward P/E ratio of 16, with an EPS growth forecast of 13%, indicating a PEG ratio close to 1, suggesting fair valuation. Despite the recent stock price decline attributed to the acquisition of Solaris, experts see this as a potential buying opportunity, highlighting consistent earnings growth and a stable yield of 1.35%. In summary, there is cautious optimism for Cardinal Health's future performance, especially in light of solid fundamentals.